Ledger.Open graph →
SEC Form D · filed July 15, 2025

Cantai Therapeutics, Inc

Offering
$1.1M
Sold
$550K
Exemption
Rule 506(b)
Industry
Biotechnology
Location
PHILADELPIA, PA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (11)

Geeta Vemuri · Philadelphia, PAExec · DirectorErrik Anderson · Philadelphia, PAExec · DirectorJoshua Brandt · Philadelphia, PADirectorRoss Leimberg · Philadelphia, PAExec · DirectorGeeta Vemuri · Philadelphia, PAExec · DirectorErrik Anderson · Philadelphia, PAExec · DirectorJoshua Brandt · Philadelphia, PADirectorCarole P. Nuechterlein · South San Francisco, CAExec · DirectorJames P. Scopa · South San Francisco, CAExec · DirectorDavid Swartz · Calabasas, CADirectorRoss Leimberg · Philadelphia, PAExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗